CAS 219716-33-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Visilizumab
CAS :Humanized monoclonal antibody targeting the CD3 receptor; possible ulcerative colitis and Chrohn's disease treatmentVisilizumab
CAS :Visilizumab is a humanized anti-CD3 IgG2 mAb with low Fc binding, modulating T-cell function for ulcerative colitis and Crohn's.Degré de pureté :95%Couleur et forme :Liquid
